Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 15/20 | 0.93 |
| ▸ | CA1 | P00915 | 13/20 | 0.93 |
| ▸ | CA9 | Q16790 | 13/20 | 0.93 |
| ▸ | CA12 | O43570 | 12/20 | 0.93 |
| ▸ | CA7 | P43166 | 5/20 | 0.93 |
| ▸ | TSHR | P16473 | 1/20 | 0.93 |
| ▸ | CA4 | P22748 | 5/20 | 0.64 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1333401 | 0.98 | CA2 (0.90) | CA2CA1CA9CA12CA7 | |
| SCHEMBL8618402 | 0.98 | CA2 (0.90) | CA2CA1CA9CA12CA7 | |
| SCHEMBL9848224 | 0.98 | CA2 (0.90) | CA2CA1CA9CA12CA7 | |
| SCHEMBL10822914 | 0.98 | CA2 (0.90) | CA2CA1CA9CA12CA7 | |
| SCHEMBL6550862 | 0.98 | CA2 (0.90) | CA2CA1CA9CA12CA7 | |
| SCHEMBL615392 | 0.96 | CA2 (1.00) | CA2CA1CA9CA12CA7 | |
| SCHEMBL5595956 | 0.89 | CA1 (1.00) | CA2CA1CA9CA12CA7 | |
| SCHEMBL19891669 | 0.89 | CA12 (0.79) | CA2CA1CA9CA12CA7 | |
| SCHEMBL28005088 | 0.88 | CA1 (0.72) | CA2CA1CA9CA12CA7 | |
| SCHEMBL28817746 | 0.87 | CA1 (0.70) | CA2CA1CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021041667-A1 | MODIFYING MESSAGES STORED IN MIXTURES OF MOLECULES USING THIN-LAYER CHROMATOGRAPHY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2021-03-04 | — | — | WO | disclosed |
| EP-2395334-B1 | THERMAL DISTRIBUTION DISPLAY AND METHOD FOR CONFIRMING THERMAL DISTRIBUTION | FUJIFILM CORP (JP) | 2016-12-28 | — | — | EP | disclosed |
| US-20120252741-A1 | NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | BIOMARIN PHARMACEUTICAL INC. (US) | 2012-10-04 | — | — | US | disclosed |
| US-20110287548-A1 | THERMAL DISTRIBUTION DISPLAY AND METHOD FOR CONFIRMING THERMAL DISTRIBUTION | FUJIFILM CORPORATION (JP) | 2011-11-24 | — | — | US | disclosed |
| US-20100105607-A1 | NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | LEAD THERAPEUTICS, INC. (US) | 2010-04-29 | — | — | US | disclosed |
| WO-2010048340-A2 | NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | LEAD THERAPEUTICS, INC. (US) | 2010-04-29 | — | — | WO | disclosed |
| US-7576036-B2 | Heat-sensitive recording material, heat-sensitive recording method and method for manufacturing heat-sensitive recording material | FUJIFILM CORPORATION (JP) | 2009-08-18 | — | — | US | disclosed |
| US-7399569-B2 | Method for producing microcapsules, microcapsules, recording material, and heat-sensitive recording material | FUJIFILM CORPORATION (JP) | 2008-07-15 | — | — | US | disclosed |
| US-7270928-B2 | Isocyanate composition, microcapsule and production method thereof, and recording material | FUJIFILM CORPORATION (JP) | 2007-09-18 | — | — | US | disclosed |
| US-20070032381-A1 | Heat-sensitive recording material, heat-sensitive recording method and method for manufacturing heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. | 2007-02-08 | — | — | US | disclosed |
| US-20030118851-A1 | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. | 2003-06-26 | — | — | US | disclosed |
| US-20030114305-A1 | Multicolor heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. | 2003-06-19 | — | — | US | disclosed |
| US-20030114302-A1 | Thermosensitive recording material | FUJI PHOTO FILM CO., LTD. | 2003-06-19 | — | — | US | disclosed |
| US-20030045426-A1 | Heat sensitive recording material and microcapsule solution | FUJI PHOTO FILM CO., LTD. | 2003-03-06 | — | — | US | disclosed |
| US-20030013608-A1 | Thermal recording material | FUJI PHOTO FILM CO., LTD. | 2003-01-16 | — | — | US | disclosed |
| US-20020187417-A1 | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. | 2002-12-12 | — | — | US | disclosed |
| US-20020172805-A1 | Thermal recording material | FUJI PHOTO FILM CO., LTD. | 2002-11-21 | — | — | US | disclosed |
| US-20020042414-A1 | Diamide compound and medicine containing the same | KOWA CO., LTD. (JP) | 2002-04-11 | — | — | US | disclosed |
| US-6340682-B1 | FOR THERAPY OF ALLERGIC IMMUNOLOGICAL DISEASE IS SELECTED FROM ASTHMA, ALLERGIC RHINITIS, INFLAMMATORY LARGE BOWEL DISEASE OR CONTACT DERMATITIS | KOWA CO., LTD. (JP) | 2002-01-22 | — | — | US | disclosed |
| US-5916680-A | CONTAINING A DIAZO COMPOUND OR AN ELECTRON DONATIVE DYE PRECURSOR, WHEREIN THE CAPSULE WALL IS COMPOSED OF AT LEAST ONE POLYMER OBTAINED BY POLYMERIZATION OF AN ISOCYANATE COMPOUND CONTAINING AN ADDUCT | FUJI PHOTO FILM CO., LTD (JP) | 1999-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105607-A1 | NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | ASNS, ALG8, ALG1 | CA2 3594/4885CA1 2552/4885CA9 2299/4885 |
| US-20020042414-A1 | Diamide compound and medicine containing the same | HRH4, HRH2, HRH1 | CA2 40/4885CA1 639/4885CA9 531/4885 |
| US-20120252741-A1 | NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | ASNS, DNPEP, ALG8 | CA2 2937/4885CA1 2394/4885CA9 2074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.